Del Carmen Jeffrey 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Del Carmen Jeffrey（CIK 1816477）在 1 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-07-17）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-17 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 卖出 | 14,337 | $451,616 |
| 2025-12-30 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 买入 | 8,667 | $0 |
| 2025-12-30 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 卖出 | 3,839 | $0 |
| 2025-12-10 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 买入 | 8,039 | $0 |
| 2025-12-10 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 卖出 | 2,492 | $0 |
| 2025-11-28 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 买入 | 10,983 | $46,238 |
| 2025-11-28 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 卖出 | 10,983 | $256,233 |
| 2025-11-24 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 买入 | 5,603 | $0 |
| 2025-11-24 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | 卖出 | 1,641 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-17